Apple reports higher sales as China reopens after coronavirus but gives no forecast
April 30, 2020
Amazon’s second-quarter forecast weighed down by $4 billion in COVID-19 related costs, shares fall
April 30, 2020

Gilead aims to expand remdesivir output for COVID-19, posts flat 1st-quarter results

Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.

Powered by WPeMatico